<PAGE>   1
                                                                   Exhibit 10.58

                             OFFICER'S CERTIFICATE

     I, the undersigned, do hereby certify and represent that:

     1. I am the duly elected Executive VP, Senior Business and Finance Officer
of deCODE genetics, Inc., a Delaware Corporation.

     2. Pursuant to Rule 306(a) of Regulation S-T, the following exhibit 10.58
to deCODE genetics, Inc.'s Annual Report on Form 10-K is a fair and accurate
English translation of a document prepared in the Icelandic language.

     IN WITNESS WHEREOF, I have signed this Officer's Certificate in my
capacity as Executive VP, Senior Business and Finance Officer of deCODE
genetics, Inc. on this 14 day of March, 2001.



                                        By:   /s/ Hannes P. Smarason
                                              --------------------------------
                                        Name: Hannes P. Smarason

                                        Title: Executive VP, Senior Business
                                               and Finance Officer


<PAGE>   2
                                                                   Exhibit 10.58


                   Contract on the Processing of Clinical Data
                 and their Transfer to a Health Sector Database
                                     between
                       The [ Name of Health Institution ]
                        hereinafter referred to as [HI],
                                       and
  Islensk erfoagreining ehf., State Reg. No. 691295-3549, Lynghals 1, Reykjavik
                hereinafter referred to as ISLENSK ERFOAGREINING;




Whereas the Minister for Health issued to Islensk erfoagreining ehf., on
22 January 2000, an Operating Licence for the Creation and Operation of a
Health Sector Database, on the basis of Act No. 139/1998, on a Health
Sector Database;

Whereas Act No. 139/1998 and the Operating Licence provide that the holder of
the Operating Licence is permitted to take delivery of data processed from
medical files for transfer to a Health Sector Database subject to the approval
of health institutions or self-employed health service workers;

Whereas the Operating Licence provides that before the commencement of transfer
of data into the Health Sector Database, the Licensee shall enter into written
contracts with the health institutions in question or self-employed health
service workers on access to information from medical records and the handling
of such information;

Whereas the [Health Institution] and Islensk erfoagreining ehf. have engaged in
negotiations and arrived at an agreement, as set out in this Contract, on the
access of Islensk erfoagreining ehf. to data from medical files in the custody
of the [Health Institution], the procedural arrangements for the processing of
such data for transfer to the Health Sector Database, and their subsequent
transfer to the Health Sector Database; The [Health Institution] and Islensk
erfoagreining ehf. hereby enter into the following



                                    Contract:
<PAGE>   3
1.    Definitions

      1.1.  All terms defined in Section 2.1. of the Operating Licence of
            Islensk erfoagreining shall have the same meaning herein, wherever
            they appear.

2.    Categories of clinical data to be processed and prepared for transfer to
      the Health Sector Database pursuant to this Contract

      2.1.  [HI] will, during the Contract Period, prepare for transfer and
            subsequently transfer to the Health Sector Database the clinical
            data specified in Annex 1 hereto and determined pursuant to Section
            3.3. hereof.

      2.2.  Islensk erfoagreining may, during the Contract Period, request that
            [HI] process and prepare for transfer to the Health Sector Database
            all the clinical data specified at any time in Annex B to the
            Operating Licence of Islensk erfoagreining, regardless of whether
            they are specified in Annex 1 hereto.

      2.3.  Annex 1A to this Contract specifies clinical data which, in addition
            to the clinical data specified in Annex B to the Operating Licence
            of Islensk erfoagreining, shall be recorded in an electronic
            clinical records file pursuant to the General Specifications for
            Clinical Records Systems in Annex A to the Islensk erfoagreining
            Operating Licence ("Supplementary Clinical Data"). [HI] agrees, for
            its part, to process and prepare for transfer to the Health Sector
            Database the Supplementary Clinical Data pursuant to Annex 1A at the
            request of Islensk erfoagreining, provided that approval has been
            obtained from the Data Protection Commission and the Monitoring
            Committee.

      2.4.  Islensk erfoagreining may, during the Contract Period, request that
            [HI] process and prepare for transfer to the Health Sector Database
            other data than those specified in Annex B to the Operating Licence
            of Islensk erfoagreining and Annex 1A hereto. In addition to the
            approval of [HI], the transfer of such data to the Health Sector
            Database shall, as applicable, be subject to the approval of the
            Data Protection Commission and the Monitoring Committee.

3.    Assessment of Classification and Volume of Clinical Data, Condition and
      Integrity

      3.1.  [HI] shall immediately on the effect of this Contract perform an
            assessment of the clinical data recorded by [HI] or in the custody
            of [HI]. The assessment shall be in the form attached hereto in
            Annex 2. The assessment shall specify the clinical data available
            and recorded, their condition, the form in which they are recorded
            and whether any clinical data require special processing in order to
            prepare them and subsequently transfer them to the Health Sector
            Database. As regards the cost of the assessment, reference is made
            to Section 12.2 hereof.

            The assessment shall also specify the clinical data recorded and
            processed by [HI] on the effective date of this Contract, the
            methods of recording and processing and the form in which the
            clinical data are recorded. Furthermore, the assessment shall
            outline any future plans of [HI] for new/altered recording of
            clinical data. An attempt shall be made to conclude [HI]'s
            assessment pursuant to this Section no later than two months
            following the date of signature of this Contract.

      3.2.  The Contracting Parties shall co-operate on the assessment of the
            quality and integrity of the clinical data of [HI], the cost and
            benefits of processing, taking into account the condition and
            usefulness of clinical data in connection
<PAGE>   4
            with this Contract. Should the parties see reason to do so, they may
            each appoint one party to work on the above projects.

      3.3.  Following the assessment and evaluation by the parties pursuant to
            the above, Islensk erfoagreining shall decide what clinical data
            [HI] pursuant to Annex 1 hereto shall be processed and prepared for
            transfer and subsequently transferred to the Health Sector Database
            pursuant to this Contract. As regards the stages of processing
            clinical data, reference is made to Article 5 hereof.

4.    Organisation of the processing of clinical data for transfer to the Health
      Sector Database

      4.1.  Processing of clinical data pursuant to this Contract shall take
            place on the premises of [HI] and in such places as activities of
            [HI] are conducted.

      4.2.  [HI] is responsible for the observation of legislation and
            regulations in the processing of clinical data for transfer to the
            Health Sector Database.

      4.3.  [HI] guarantees that all processing of clinical data for transfer to
            the Health Sector Database will be performed, or its performance
            managed, by qualified health-care personnel of the [HI].

      4.4.  [HI] shall provide Islensk erfoagreining with information on which
            employees of [HI] are directly involved in transferring clinical
            data to the Health Sector Database. Islensk erfoagreining shall
            ensure that such employees are not involved in the operation of the
            Health Sector Database.

      4.5.  [HI] and Islensk erfoagreining will jointly organise regular courses
            and training for the employees of [HI] on the processing of data for
            transfer to the Health Sector Database in order to ensure the
            quality and integrity of clinical data.

      4.6.  In the event that it proves necessary to label and amend clinical
            data, [HI] will perform this work in consultation with Islensk
            erfoagreining and in accordance with the rules and procedures
            specified in Annex 3 hereto.

      4.7.  The arrangements and implementation of the processing of clinical
            data and their preparation for transfer to the Health Sector
            Database are divided into four stages, as further specified in
            Article 5 hereof.

5.    Stages in the Processing of Clinical Data and their Transfer to a Health
      Sector Database

      5.1.  Stage 1: older clinical data in machine-readable form

            5.1.1. The first stage covers clinical data in machine-readable
                  form, recorded and preserved by the [HI] on the effective date
                  of this Contract.

            5.1.2. [HI] undertakes to process and prepare for transfer to the
                  Health Sector Database, pursuant to Stage 1, the classes of
                  clinical data specified in Annex 1 hereto, subject, however,
                  to Section 3.3. The intention is to process clinical data
                  dating back to 1986, cf. Section 4.6 in the Operating Licence
                  of Islensk erfoagreining, with due consideration to usefulness
                  and cost.

      5.2.  Stage 2: clinical data recorded on documents and paper

            5.2.1. Stage 2 covers clinical data recorded on documents and paper.

            5.2.2. [HI] undertakes to process clinical data available on paper
                  and documents in [HI] and prepare them for transfer to the
                  Health Sector
<PAGE>   5
                  Database. Classes of clinical data to be processed for
                  transfer to the Health Sector Database in stage 2 are
                  specified in Annex 1 hereto, subject, however to Section 3.3.

      5.3.  Stage 3: Processing of clinical data using medical filing systems
            used by [HI] in its activities on the effective date of this
            Contract.

            5.3.1. Stage 3 covers processing of clinical data using medical
                  filing systems used by [HI] in its activities on the effective
                  date of this Contract.

            5.3.2. [HI] and Islensk erfoagreining shall in joint consultation
                  conduct an assessment of the medical filing systems used by
                  [HI] in its recording and processing of clinical data.

            5.3.3. The assessment shall cover all the principal disadvantages of
                  the current medical filing systems and the impact they have or
                  may have on the processing of the clinical data subject to
                  processing under this Contract. The parties may decide to make
                  temporary improvements in the current medical file systems, if
                  both agree that this is necessary, in order to make it
                  possible to process clinical data under Stage 3.

            5.3.4. [HI] undertakes to process and prepare for transfer to the
                  Health Sector Database, pursuant to Stage 3, the classes of
                  clinical data specified in Annex 1 hereto, subject, however,
                  to Section 3.3.

      5.4.  Stage 4: Processing of clinical data using the Integrated Health
            Institution Clinical Records System

            5.4.1. An agreement has been reached to the effect that [HI] will
                  take into use an Integrated Clinical Records System, as
                  further detailed in Article 8 hereof. After [HI] has taken
                  such a clinical records system into use, [HI] clinical data
                  will recorded and processed based on the structure of the
                  electronic Clinical Records Systems based on the general
                  specifications of the Ministry of Health and Social Security.
                  Coded and other numerical data defined in Annex B to the
                  Operating Licence of Islensk erfoagreining, "Transfer of Data
                  to the to the Health Sector Database", shall be transferred
                  from the electronic clinical records systems to the Health
                  Sector Database through the Encryption Agency of the Data
                  Protection Commission.

      5.5.  Transfer of Clinical Data from Independent Systems

            5.5.1. On the date of effect of this Contract, or at any time during
                  its term of effect, there may be in existence at [HI]
                  independent systems created for scientific research and other
                  activities not directly related to patient services and/or
                  independent systems set up for experimental or development
                  purposes. Should Islensk erfoagreining request that [HI]
                  transfer clinical data from such systems to the Health Sector
                  Database, [HI] will accede to such request, assuming there are
                  no reasonable grounds for refusal in specific cases, provided
                  that an agreement has been reached between Islensk
                  erfoagreining and the originators and owners of such systems,
                  to the extent that such originators and owners are not [HI]
                  itself, and provided also that approval has been obtained from
                  the Data Protection Commission and the Monitoring Committee,
<PAGE>   6
                  as applicable. Work on preparations for such transfer shall
                  then be integrated into project stages pursuant to the above,
                  as applicable.

6.    Start of Processing of Clinical Data at [HI] for Transfer to the Health
      Sector Database Pursuant to this Contract

      6.1.  It is the understanding of the parties that processing of clinical
            data pursuant to Stage 1 will begin following assessment of clinical
            data pursuant to Article 3 and following a decision pursuant to
            Section 3.3.

      6.2.  It is understood that processing of clinical data pursuant to Stage
            2 will begin following assessment of clinical data pursuant to
            Article 3 and following a decision pursuant to Section 3.3.

      6.3.  It is understood that processing of clinical data pursuant to Stage
            3 will begin when approval has been obtained for the transfer of
            clinical data processed under this Contract to the Health Sector
            Database and that such processing will continue until processing
            pursuant to Stage 4 begins.

      6.4.  It is understood that processing of clinical data and their transfer
            to the Health Sector Database pursuant to Stage 4 will begin when
            [HI] takes into use a clinical records system meeting the general
            specifications of the Ministry of Health and Social Security for
            clinical records systems.

7.    Arrangements for the transfer of clinical data to the Health Sector
      Database

      7.1.  Preparations for the transfer of clinical data to the Health Sector
            Database will take place under the management and on the
            responsibility of [HI] pursuant to the provisions hereof. Personal
            identifiers will be encrypted one way at [HI]. Clinical data shall
            be transferred in encrypted form to the Data Protection Commission
            Encryption Agency.

      7.2.  [HI] will perform and take responsibility for the transfer of
            clinical data pursuant to this Contract from the [HI] to the Data
            Protection Commission Encryption Agency. [HI] shall observe the
            terms of the Data Protection Commission.

      7.3.  Islensk erfoagreining will supply software and hardware for the
            encryption and transfer of clinical data from [HI] to the Data
            Protection Commission Encryption Agency.

      7.4.  The frequency and details of the transfer of clinical data processed
            for transferring and subsequent transfer to the Health Sector
            Database to the Data Protection Commission Encryption Agency shall
            be subject to further agreement between the parties.

8.    Integrated Clinical Records System

      8.1.  Pursuant to the provisions of the Operating Licence of the company
            and the further provisions of this Article 8, Islensk erfoagreining
            will co-operate with [HI] on installing at [HI] a clinical records
            system conforming to the General Specifications for Clinical Records
            Systems of the Ministry of Health and Social Security, as current at
            any time, and other conditions of the Operating Licence, as well as
            the special requirements of Islensk erfoagreining regarding the
            recording and processing of clinical data for transfer and their
            subsequent transfer to the Health Sector Database. With the
            integrated clinical records system, the recording and processing of
            clinical data at [HI] will be standardised in all the data recording
            systems used by the [HI] at any
<PAGE>   7
            time to record clinical data in its activities. "Data recording
            systems" refers to computer software used by health sector personnel
            to record clinical data in the course of their work. An integrated
            clinical records system consists of data recording systems,
            communications systems capable of retrieving and providing access to
            clinical data from individual data recording systems, and a user
            interface that displays clinical data provided by the communications
            system. The integrated clinical records systems shall be capable of
            sending and receiving clinical data over the Icelandic Health
            Network currently in preparation by the Health Authorities.

      8.2.  In the course of the installation of the integrated clinical records
            system at [HI] it will be determined to what extent it is possible,
            and feasible, for both contracting parties to continue to use the
            data recording systems being used by [HI] for the recording of
            clinical data on the effective date of this Contract. The parties
            shall jointly conduct an assessment of the data recording systems in
            question and the contracts concluded with their proprietors.

      8.3.  Following the joint assessment pursuant to Section 8.2, and, as
            applicable, following negotiations with the proprietors of the
            systems in question, the parties shall make a decision on what data
            recording systems will continue in use as part of the integrated
            clinical records system of [HI], and what data recording systems
            will be discontinued. In arriving at decisions in this respect,
            account shall be taken of the experience of [HI] of the data
            recording systems in question, the future prospects of the systems
            in the light of other available options, their usefulness in
            processing clinical data for the Health Sector Database, and the
            reasonable interests of Islensk erfoagreining in achieving
            co-ordination and minimising the costs of the methods and solutions
            of taking into use the integrated clinical records systems selected
            by individual health institutions and self-employed health service
            workers with whom Islensk erfoagreining contracts for the processing
            of clinical data for transfer to the Health Sector Database and
            their subsequent transfer.

      8.4.  In the event of a decision, following assessment pursuant to Section
            8.2, to discontinue the user of a data recording system in use at
            [HI], or if there is a need to add a new data recording system,
            Islensk erfoagreining shall, in consultation with [HI] and with due
            consideration to the special needs of both parties, create, have
            created, or purchase such a data recording system and supply it to
            [HI]. Islensk erfoagreining shall, in the same way, create, have
            created or purchase and supply to [HI] communications systems and
            user interfaces for the integrated clinical records system.

      8.5.  [HI] shall be a formal contracting party vis-a-vis the owners of the
            proprietary rights to the data recording systems to be used pursuant
            to this Contract in the recording and processing of clinical data,
            and vis-a-vis the owners of communications systems and user
            interfaces for the integrated clinical records system. All such
            contracts and amendments to them shall be subject to the consent of
            Islensk erfoagreining. Payments of licence fees shall be subject to
            Section 12.1.

      8.6.  After the integrated clinical records system has been taken into use
            at [HI], the participation of Islensk erfoagreining in the cost of
            the renewal of data
<PAGE>   8
            recording systems, communications systems and user interface, and
            the installation of additional systems shall be subject to the prior
            approval of Islensk erfoagreining. The same applies to costs of
            updating or increasing the capacity of data recording systems,
            communications systems or user interface for the integrated clinical
            records system. The creation of new systems shall be subject to the
            provisions of Section 8.4.

      8.7.  In the event that a data recording system, communications system or
            user interface used by [HI] as part of the integrated clinical
            records system has become inefficient, e.g. for technical,
            professional or financial reasons, Islensk erfoagreining and [HI]
            shall jointly decide whether a request should be made to the owner
            of the proprietary rights to the system for amendments to the
            contract or whether the contract should be terminated. Both Islensk
            erfoagreining and [HI] may take the initiative as regards the review
            of a contract with the owner of the proprietary rights to such
            system pursuant to the above.

9.    Development Projects

      9.1.  Islensk erfoagreining and [HI] will explore the potential for
            co-operation during the term of this contract as regards development
            projects relating to the creation and utilisation of clinical
            records systems or other related projects. The parties shall enter
            into separate contracts on each such project.

10.   The Share of Islensk Erfoagreining in Payments to [HI] in Respect of
      Third-Party Access Granted by [HI] to the Clinical Records System

      10.1. In the event that [HI] or employees of [HI], alone or in
            co-operation with other parties, use the clinical records system set
            up at [HI] pursuant to Article 8 for research, and [HI] receives
            payments from a third party in respect of the research, Islensk
            erfoagreining shall be entitled to a share of such third-party
            payments or their value (e.g. if payments take the form of
            instruments or other equipment) following deduction of direct costs
            of [HI] of the research in question. The share of Islensk
            erfoagreining shall be 35%, unless the parties hereto agree
            otherwise in individual cases. [HI] shall immediately inform Islensk
            erfoagreining of any events giving rise to payments to [HI] pursuant
            to the above. Payment of shares to Islensk erfoagreining shall be
            made within 10 days of receipt by [HI] of individual third-party
            payments. Islensk erfoagreining shall be entitled to have a
            chartered accountant appointed by Islensk erfoagreining verify that
            payments to Islensk erfoagreining in compliance with the above
            provisions. The accountant shall be entitled, for this purpose, to
            examine the payment clauses of contracts made by [HI] with third
            parties regarding the above, as well as accounting documents and
            other documents of [HI] as necessary at his discretion.

11.   Confidentiality

      11.1. The contracting parties and their employees shall keep in confidence
            everything of which they may become aware in the course of their
            work regarding the activities of each other. The confidentiality
            shall remain in effect following the end of the Contract.

      11.2. The contracting parties declare that they and their employees will
            treat information regarding this contract and its implementation as
            confidential,
<PAGE>   9
            subject to the obligation of [HI] to provide information under the
            Information Act.

12.   Payments of Islensk Erfoagreining for Processing of Clinical Data Pursuant
      to this Contract

      12.1. Islensk erfoagreining will pay the cost of creating an integrated
            clinical records system, cf. Article 8, and new version thereof, and
            [HI] will refund license fees in respect of licence contracts with
            the owners of the proprietary rights.

      12.2. Islensk erfoagreining will pay the cost of assessment pursuant to
            Article 3, including wage costs and other costs of [HI].

      12.3. Islensk erfoagreining will pay the wage costs and operating costs of
            [HI] resulting from the processing of clinical data for transfer to
            the Health Sector Database. This cost shall be specified in a
            separate cost and time schedule prepared jointly by the parties
            hereto when the assessment pursuant to Article 3 has been carried
            out and the decision of Islensk erfoagreining pursuant to Section
            3.3 on the processing of clinical data for transfer to the Health
            Sector Database has been made. The schedule shall describe the
            project stages and set out the project schedule, and estimate the
            human resources required and other costs for each stage, cf. Article
            5. The schedule shall furthermore estimate the cost of teaching and
            training health care employees in the recording and processing of
            clinical data. In the event of part-time employment of an [HI]
            employee, who is also engaged in other work, the proportion of work
            shall be determined in the preparation of the cost estimate. [HI]
            guarantees that the project schedule will be observed. The cost and
            time schedule shall be subjected to review once every six months.
            Islensk erfoagreining may suspend payment for work which is
            demonstrably not performed pursuant to the schedule, provide that
            there is no reasonable justification for such deviation. [HI] may
            halt the transfer of clinical data pursuant to this Contract to the
            Encryption Agency if Islensk erfoagreining does not effect payments
            pursuant to this contract.

      12.4. Islensk erfoagreining will supply [HI] with and pay [HI]'s costs of
            special hardware and/or software necessary to enable processing of
            clinical data for transfer to the Health Sector Database pursuant to
            stages 1 and 2. Islensk erfoagreining will also pay the cost of
            software and hardware for the encryption and transfer of clinical
            data from [HI] to the Data Protection Commission Encryption Agency
            which Islensk erfoagreining supplies to [HI] pursuant to Section
            7.3. Furthermore, Islensk erfoagreining will pay all
            telecommunications cost relating to the transfer of clinical data
            from [HI] to the Data Protection Commission Encryption Agency.

      12.5. [HI] and the employees of [HI] may, at no separate cost, submit
            queries to the Health Sector Database for their own research
            conducted by themselves. Such queries shall be subject to normal
            rules on queries to the Health Sector Database. The above permission
            of [HI] and [HI] employees does not extend to queries made for third
            parties or in respect of scientific research or other projects
            conducted in co-operation with third parties which pay [HI] or [HI]
            employees for their roles in the research. Such queries and payments
            for them
<PAGE>   10
            to Islensk erfoagreining shall be treated as third-party queries to
            the Health Sector Database. Islensk erfoagreining shall be entitled
            to receive from [HI] or the employees of [HI] who submit queries to
            the Health Sector Database based on the above provision satisfactory
            information on the nature of and the parties responsible for the
            scientific research in question in order to clarify whether the
            query falls under the said provision. Islensk erfoagreining may
            refuse a request of [HI] or employees of [HI] for processing of a
            query without special payment if Islensk erfoagreining has
            reasonable grounds for believing that the provisions of this Article
            are being violated.

13.   Term of Effect of the Contract

      13.1. This contract shall take effect on its confirmation by the
            Monitoring Committee, cf. Article 19, as of its date of signature.
            The Contract shall remain in effect while Islensk erfoagreining is
            in possession of an operating licence pursuant to law for the
            creation and operation of a Health Sector Database.

      13.2. If [HI] is merged with another health institution, or its activities
            or scope of activities are changed, with the result that the basis
            for this Contract is altered, Islensk erfoagreining may request a
            review of its terms.

      13.3. In entering into this Contract, the parties recognise that it is
            impractical to make provisions for every contingency which may arise
            during the effective term of the Contract. The parties declare it to
            be their intention that the Contract shall be operated between them
            with fairness.

      13.4. Should however the occurrence of events, including fundamental
            changes in the arrangement or implementation of health services at
            [HI], or in the basis for operation of the Health Sector Database,
            beyond the control of the parties, and not reasonably foreseeable by
            the parties on entering into this Contract, and if such events have
            the effect that the premises of either party for entering into the
            Contract are fundamentally altered with the result that the
            unchanged operation of the Contract would cause unfairness to that
            party, the parties will meet and in good faith negotiate and use
            their best endeavours to agree upon an amendment to this agreement
            to counteract such unfairness. In the event that the parties are
            unable to agree as to the existence of such unfairness or reactions
            to such unfairness, either party may refer the dispute to
            arbitration pursuant to Article 17 hereof. Notwithstanding the
            foregoing, neither party may invoke the provisions of this Section
            13.4 prior to 22 January 2006, or more than one time during the term
            of the original Operating Licence of Islensk erfoagreining, or more
            than one time during the term of an extended or new Operating
            Licence for Islensk erfoagreining.

14.   End of the contract

      14.1. At the end of this Contract, [HI] is entitled, against reasonable
            remuneration, to a licence to software owned by Islensk
            erfoagreining and custom made for [HI] for the recording and
            processing of clinical data. The licence shall cover the right to
            further development of such software for use in the activities of
            [HI]. All such additions and improvements shall be delivered to
            Islensk erfoagreining as they come into existence. Islensk
            erfoagreining will be the
<PAGE>   11
            owner of all such additions and improvements with unlimited rights
            of utilisation and disposal.

15.   Contracting

      15.1. The contracting parties may contract with other parties to perform
            work on their behalf on individual components of this Contract with
            the prior approval of the Monitoring Committee and/or the Data
            Protection Commission, where the component in question requires the
            consent of those parties. If the parties employ another party to
            perform its contractual obligations hereunder, they shall guarantee
            the work of such party to the other party pursuant to the provisions
            hereof.

16.   Operation of the Contract

      16.1. [HI] and Islensk erfoagreining shall hold regular progress meetings
            on the operation of this Contract. A record of minutes shall be kept
            of proceedings of meetings and the parties shall have equal access
            to the minutes.

17.   Settlement of Disputes

      17.1. In the event of any dispute regarding the interpretation of this
            Contract, and if no agreement can be reached between the parties on
            the issue in dispute, an arbitration tribunal composed of three
            arbitrators, one nominated by each party and a third nominated by
            the District Court of Reykjavik, shall resolve the dispute. In other
            respects, the arbitration and arbitration proceedings shall be
            governed by Act No. 53/1989 on Contractual Arbitration.

      17.2. Notwithstanding the provisions of Section 17.1, a contracting party
            who believes that a quick settlement is needed may submit the
            dispute to an arbitrator agreed by both contracting parties on the
            signature of this Contract or subsequently selected as his
            replacement. The arbitrator shall submit an interim decision
            regarding the dispute within 7 days of the submission of the
            dispute. The decision shall be based only on documents submitted
            before the said deadline and before the arbitrator accepts the
            dispute for decision. The arbitrator shall decide which party shall
            bear the cost of his work and the amount of the cost. In other
            respects, the work of the arbitrator and rules of procedure shall be
            governed by Act No. 53/1989 on Contractual Arbitration. The decision
            of the arbitrator can be submitted to arbitration pursuant to
            Section 17.1, provided that this is done within 14 days from the
            delivery of his decision.
<PAGE>   12
18.   Miscellaneous Provisions

      18.1. [HI] shall take regular backup copies of clinical data recorded in
            its data recording systems. The frequency and arrangements of such
            backing up shall be in accordance with accepted practice.

19.   Approval of the Monitoring Committee

      19.1. This Contract is concluded subject to the approval of the Monitoring
            Committee.



                          [Place of signature], [Date]


    For the [Health Institution]         For Islensk erfoagreining ehf.



   ------------------------------        ------------------------------
                                             Kari Stefansson, CEO.